Explore

Trendline Trendline
Amylyx Pharmaceuticals to Announce Q1 2026 Financial Results Amid Strategic Focus on Neurodegenerative Diseases

Amylyx Pharmaceuticals to Announce Q1 2026 Financial Results Amid Strategic Focus on Neurodegenerative Diseases

Amylyx Pharmaceuticals to Announce Q1 2026 Financial Results Amid Strategic Focus on Neurodegenerative Diseases
Trendline Trendline
DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update

DiaMedica Therapeutics to Announce Q1 2026 Financial Results and Business Update
Trendline Trendline
Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026

Lucid Diagnostics Announces Upcoming Business Update Conference Call for Q1 2026
Trendline Trendline
Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast

Co-Diagnostics to Release Q1 2026 Financial Results and Host Webcast
Trendline Trendline
Mid-America Apartment Communities Reports First Quarter 2026 Financial Results Indicating Strong Resident Retention

Mid-America Apartment Communities Reports First Quarter 2026 Financial Results Indicating Strong Resident Retention

Mid-America Apartment Communities Reports First Quarter 2026 Financial Results Indicating Strong Resident Retention
Trendline Trendline
Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy

Novocure Reports Strong Q1 2026 Financial Results with Growth in Optune Gio Therapy
Trendline Trendline
CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance

CareDx Reports 39% Revenue Growth in Q1 2026, Raises Annual Guidance
Trendline Trendline
STAG Industrial Reports Strong Q1 2026 Results with Increased Leasing Activity

STAG Industrial Reports Strong Q1 2026 Results with Increased Leasing Activity

STAG Industrial Reports Strong Q1 2026 Results with Increased Leasing Activity
Trendline Trendline
Uwharrie Capital Corp Reports Increased Net Income for Q1 2026 Amid Asset Growth

Uwharrie Capital Corp Reports Increased Net Income for Q1 2026 Amid Asset Growth

Uwharrie Capital Corp Reports Increased Net Income for Q1 2026 Amid Asset Growth
Trendline Trendline
Intellia Therapeutics Advances CRISPR Drug for Hereditary Angioedema with Phase 3 Success

Intellia Therapeutics Advances CRISPR Drug for Hereditary Angioedema with Phase 3 Success

Intellia Therapeutics Advances CRISPR Drug for Hereditary Angioedema with Phase 3 Success
Trendline Trendline
Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment

Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment

Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment
SB Nation SB Nation
Duke Recruiting: A Sudden Tug-of War With UNC?

Duke Recruiting: A Sudden Tug-of War With UNC?

Joaquim Boumtje Boumtje could, quite quickly, spark a major recruiting battle between Duke and UNC.